Company : GlycoMar Limited

Category : Biotechnology

Drug discovery

GlycoMar is uniquely focused on the development of novel therapies based on saccharide molecules from marine organisms. These molecules offer a unique therapeutic approach with an excellent safety profile. The company has developed a unique library of polysaccharides and glycosaminoglycans. The molecules have been the subject of compositional analysis and structural characterisation. Anti-inflammatory screening has shown a high hit rate of valuable activity, which is being developed for treatment of psoriasis, inflammatory bowel disease, and respiratory inflammatory disease in collaboration with a pharmaceutical partner.

GlycoMar is seeking partners for its psoriasis and inflammatory bowel disease programme. GlycoMar is also interested to talk to commercial partners interested in testing out molecules in other disease indications.

Other Products

Nutraceutical discovery

Drug discovery screening

Glycobiology analytical services